Phase I Study of Umbilical Cord Blood Natural Killer (NK) Cell Therapy for Children With High-risk, R/R Neuroblastoma.
Clinical trial NCT06631391 · RECRUITING
Trial details
- NCT number
- NCT06631391
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-01
- Primary completion
- 2026-11-30
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.